Role of Clp proteins in the biogenesis of the malaria parasite plastid
Role of Clp proteins in the biogenesis of the malaria parasite plastid
批准号:
9226266
负责人:
Vasant Muralidharan
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-07 至 2018-11-30
关键词:
ATP phosphohydrolaseAdverse effectsAffectAlgaeAntibioticsAntimalarialsAreaAutomobile DrivingBacteriaBiochemicalBiogenesisBiologicalBiological AssayBiological ProcessBiologyCRISPR/Cas technologyCarrier ProteinsCell divisionCellsCessation of lifeChloroplastsChromosome MappingClinicalCloningComplexDataDiseaseDrug TargetingDrug resistanceErythrocytesEukaryotic CellGene TargetingGenesGeneticGenetic MaterialsGenome engineeringGoalsGrowthHandHumanIn VitroMalariaMeasuresMetabolic PathwayMetabolismModelingMolecularMolecular ChaperonesNuclearOrganellesParasitesPathway interactionsPeptide HydrolasesPharmaceutical PreparationsPlantsPlasmodiumPlasmodium falciparumPlastidsPlayProcessProtein FamilyProtein ImportProteinsProtocols documentationResearchResistanceResistance developmentRoleSeriesSignal TransductionSystemTestingUsher ProteinsVaccinesVirulence FactorsWorkbasecomplex Rconditional mutantdaughter celldrug developmentendosymbiontexperimental studygenetic manipulationgenetic regulatory proteinhuman diseaseimprovedin vivoinsightkillingsknock-downmortalitynovelobligate intracellular parasitepathogenprotein transportproteostasisresistant strainsegregationsmall moleculesuccess
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Plasmodium falciparum is a deadly parasite that causes malaria in humans and is responsible for nearly
600,000 deaths very year. Malaria is endemic in large regions of the world infecting nearly ~300 million people
every year. There are no effective vaccines against malaria and antimalarial drugs are the mainstay of
treatment. Unfortunately, the parasite has gained resistance to all clinically available antimalarial drugs and
these drug-resistant strains are spreading throughout the world. This is threatening all the progress that has
been made against this disease in the last decade. Thus, it is imperative that we constantly identify potential
drug targets to stay ahead of this nefarious disease. The parasites from the genus Plasmodium that cause
malaria are single celled, eukaryotic pathogens. Since human cells are also eukaryotic, it can be tricky to
develop drugs that specifically kill the parasite and don't have too many side effects. The parasitic Plasmodium
cell is amazingly complex with two organelles that carry their own genetic material, the mitochondrion and a
unique plastid of algal origin known as the apicoplast. The apicoplast is present only in the parasite and not in
the human host. This makes it an ideal drug target since attacking the apicoplast will affect only the parasite
and not the human host. In fact, some antibiotics have shown success as antimalarial drugs because they
target essential biological processes in the apicoplast. However, the molecular mechanisms that drive the
biology of this unique parasite organelle remain unknown, which hampers antimalarial drug development. The
proposed studies target an important set of genes that we hypothesize to act as key regulators for the
biogenesis of the apicoplast. Our preliminary data show that one of the targeted genes is essential for parasite
growth underscoring the importance of this pathway in the biology of P. falciparum. We will apply genetic,
cellular, and biochemical approaches to characterize the various roles that these genes play in the biogenesis
of this essential parasite organelle. Attaining the aims of this proposal will uncover the novel biology of the
apicoplast and identify parasite-specific essential proteins that can be targeted for antimalarial drug
development.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exocytosis of Plasmodium egress and invasion organelles
-
批准号:10888455
-
项目类别:
-
资助金额:$54.02万
-
财政年份:2023
-
负责人:Vasant Muralidharan
-
依托单位:
Elucidating the trafficking mechanisms of effector proteins to the Plasmodium infected red blood cell
-
批准号:10411532
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2022
-
负责人:Vasant Muralidharan
-
依托单位:
Essential function of a putative glycosyltransferase in P. falciparum
-
批准号:10382321
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2021
-
负责人:Vasant Muralidharan
-
依托单位:
Essential function of a putative glycosyltransferase in P. falciparum
-
批准号:10215886
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2021
-
负责人:Vasant Muralidharan
-
依托单位:
Diversity Supplement for Elucidating the trafficking mechanisms of effector proteins to the Plasmodium infected red blood cell
-
批准号:10077624
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2018
-
负责人:Vasant Muralidharan
-
依托单位:
Elucidating the trafficking mechanisms of effector proteins to the Plasmodium infected red blood cell
-
批准号:10319936
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2018
-
负责人:Vasant Muralidharan
-
依托单位:
ROLE OF CHAPERONES IN MAINTAINING THE ASPARAGINE REPEAT-RICH PROTEOME OF P. FALCI
-
批准号:8281043
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2012
-
负责人:Vasant Muralidharan
-
依托单位:
ROLE OF CHAPERONES IN MAINTAINING THE ASPARAGINE REPEAT-RICH PROTEOME OF P. FALCI
-
批准号:8616715
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Vasant Muralidharan
-
依托单位:
ROLE OF CHAPERONES IN MAINTAINING THE ASPARAGINE REPEAT-RICH PROTEOME OF P. FALCI
-
批准号:8590831
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2012
-
负责人:Vasant Muralidharan
-
依托单位:
海外基金